AI Article Synopsis
- Recent studies indicate that MRI scans can be safely conducted in selected patients with pacemakers or ICDs, without significant risks related to peak SAR levels.
- Thirty-seven patients underwent 40 MRI scans, with cardiac troponin-I and myoglobin levels measured before and after the scans, showing no significant changes post-MRI.
- The findings support the idea that MRI procedures pose minimal risk of myocardial damage in these patients, as evidenced by stable biomarker levels and unchanged pacemaker capture thresholds before and after imaging.
Article Abstract
Background: Recent series suggest that magnetic resonance imaging (MRI) scanning can be performed safely in select patients with pacemakers or implantable cardioverter-defibrillators (ICDs). Limited data have been reported on cardiac biomarker release following MRI scans in patients with pacemakers. The current study evaluated cardiac biomarkers pre- and postscan in patients with permanent pacemakers or ICDs undergoing MRI scanning of any body region without peak specific absorption rate (SAR) limit.
Methods: Thirty-seven patients with a total of 75 leads underwent a total of 40 MRI scans of both truncal and nontruncal regions using usual protocols with standard peak SAR settings for the scan. No patient was pacemaker dependent. Pacemaker magnet mode and ICD therapy were disabled during the scan. Baseline cardiac troponin-I and myoglobin levels were obtained immediate pre- and 6-12 hours postscan. Pacemaker capture thresholds were measured immediately pre- and postscan.
Results: The median peak SAR was 2.4 (1.3, 3.2) W/kg for all scans. Cardiac troponin-I was unchanged following an MRI scan (0.01 (0.01, 0.02) versus 0.01 (0.01, 0.02) ng/mL, P = 0.90). Capture thresholds were no different pre- and postscan (0.67 (0.50, 0.80) versus 0.70 (0.50, 0.79) V at 0.5 ms, P = 0.50).
Conclusions: The current series suggests that an MRI scan may be performed safely in carefully selected patients with close monitoring during the scan without limitation on peak SAR level or body landmark. Furthermore, it is unlikely that an MRI scan will produce sufficient tissue heating to cause enough myocardial cell necrosis to result in cardiac biomarker release.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1540-8159.2008.01172.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Reconstructing Covert Consciousness: Neural Decoding as a Novel Consciousness Assessment.
Neurology
February 2025
Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Determining the level of consciousness in patients with brain injury-and more fundamentally, establishing what they can experience-is ethically and clinically impactful. Patient behaviors may unreliably reflect their level of consciousness: a subset of unresponsive patients demonstrate covert consciousness by willfully modulating their brain activity to commands through fMRI or EEG. However, current paradigms for assessing covert consciousness remain fundamentally limited because they are insensitive, rely on imperfect assumptions of functional neuroanatomy, and do not reflect the spectrum of conscious experience.
View Article and Find Full Text PDFLong-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS: Nine-Year Data From the OPERA Studies Open-Label Extension.
Neurology
February 2025
Department of Neurology and Center of Clinical Neuroscience, First Medical Faculty, General University Hospital and Charles University, Prague, Czech Republic.
Background And Objectives: Patients with multiple sclerosis (MS) may demonstrate better disease control when treatment is initiated on high-efficacy disease-modifying therapies (DMTs) from onset. This subgroup analysis assessed the long-term efficacy and safety profile of the high-efficacy DMT ocrelizumab (OCR) as first-line therapy for early-stage relapsing MS (RMS).
Methods: Post hoc exploratory analyses of efficacy and safety were performed in a subgroup of treatment-naive patients with RMS who received ≥1 dose of OCR in the multicenter OPERA I/II (NCT01247324/NCT01412333) studies.
Intraprocedural Three-Dimensional Imaging Registration Optimizes Magnetic Resonance Imaging-Guided Focused Ultrasound and Facilitates Novel Applications.
Oper Neurosurg (Hagerstown)
November 2024
Department of Neurosurgery, University of Pennsylvania Health System, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Background And Objective: Transcranial magnetic resonance-guided focused ultrasound (MRgFUS) has revolutionized ablative treatment of essential tremor in recent years. However, limitations in precision targeting may account for suboptimal efficacy and significant side effects. We describe a simple intraprocedural three-dimensional image-guided lesion shaping technique that can improve overall outcomes of MRgFUS for essential tremor and facilitate expansion to novel indications.
View Article and Find Full Text PDFClinical Evaluation of the NaviNetics Stereotactic System Using Intraoperative Portable Surgical Imaging System in DBS Surgery.
Oper Neurosurg (Hagerstown)
November 2024
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Background And Objectives: A typical workflow for deep brain stimulation (DBS) surgery consists of head frame placement, followed by stereotactic computed tomography (CT) or MRI before surgical implantation of the hardware. At some institutions, this workflow is prolonged when the imaging scanner is located far away from the operating room, thereby increasing workflow times by the addition of transport times. Recently, the intraoperative O-arm has been shown to provide accurate image fusion with preoperative CT or MR imaging, suggesting the possibility of obtaining an intraoperative localization scan and postoperative confirmation.
View Article and Find Full Text PDFUltra-Low-Field Portable Brain Magnetic Resonance Imaging in Patients With Cardiac Devices: Current Evidence and Future Directions.
ASAIO J
January 2025
From the Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
The use of cardiac devices, including mechanical circulatory support (MCS), cardiac implantable electronic devices (CIEDs), and pacing wires, has increased and significantly improved survival in patients with severe cardiac failure. However, these devices are frequently associated with acute brain injuries (ABIs) including ischemic strokes, intracranial hemorrhages, seizures, and hypoxic-ischemic brain injury which contribute substantially to morbidity and mortality. Computed tomography (CT) and magnetic resonance imaging (MRI), the standard imaging modalities for ABI diagnosis, can pose significant challenges in this patient population due to the risks associated with patient transportation and the incompatibility of ferromagnetic components of certain cardiac devices with high magnetic field of the MRI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!